Esperion Sets Offering Of Stock, Rising On Clinical Trial Success
ANN ARBOR — The Ann Arbor pharmaceutical developer Esperion Therapeutics Inc. (Nasdaq: ESPR) said it would offer 1.75 million new shares of the company to the public at a price …
Esperion Stock Offering Sold Out
ANN ARBOR — Turns out there was no problem with the demand for stock in the Ann Arbor cholesterol-busting drug developer Esperion Therapeutics Inc. (Nasdaq: ESPR). The company announced Tuesday …
Esperion Therapeutics Prices Stock Offering: $20 A Share
ANN ARBOR — Esperion Therapeutics Inc. (Nasdaq: ESPR) has priced the offering of 4.25 million shares of its common stock at $20 a share. The offering is expected to provide $85 …
Esperion Sets Public Stock Offering
ANN ARBOR — Esperion Theapeutics Inc. (Nasdaq: ESPR), the developer of a new class of cholesterol-fighting drugs, has announced the intention to sell $85 million of its stock in a …
Arotech Stock Offering Sells Out
ANN ARBOR — The defense and simulation product developer Arotech Corp. (NasdaqGM: ARTX) says the underwriter of its recent public stock offering of 2.86 million shares has exercised in full …
Advanced Photonix Prices Stock Offering
ANN ARBOR — The Ann Arbor electronics and optics manufacturer Advanced Photonix Inc. (NYSE: API) said it has priced a public stock offering of almost 5.4 million shares at 53 cents per …